⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Continuity Biosciences beruft Vicky Papoutsis in den Vorstand
prnewswire.com
ABBV
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
businesswire.com
ABBV
APGE
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
prnewswire.com
JNJ
MRK
TEVA
LLY
ABBV
PFE
AZN
Continuity Biosciences nombra a Vicky Papoutsis miembro de su consejo de administración
prnewswire.com
ABBV
Continuity Biosciences nomme Vicky Papoutsis au conseil d'administration
prnewswire.com
ABBV
DIS
JUVÉDERM® Day Returns to U.S. on August 19
prnewswire.com
ABBV
Fraud Detection and Prevention (FDP) in BFSI Market worth $15.06 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MA
T
IBM
FIS
FISV
AXP
V
PYPL
COF
BK
BAC
JPM
WFC
C
MS
GS
SCHW
AXS
ALL
CB
PGR
TRV
UNM
MET
PRU
AIG
L
AIZ
SIGI
ENR
LNC
AGNC
IVZ
AMP
ICE
EQIX
AMZN
GOOGL
MSFT
NVDA
AMD
INTC
CSCO
ADBE
CRM
ORCL
SAP
ACN
GOOG
AMAT
MU
QCOM
TXN
INTU
ADP
PAYX
DXC
CTSH
INFY
WDC
SE
MELI
BABA
JD
NTES
PDD
BIDU
IQ
VIPS
XPEV
NIO
LI
LCID
RIVN
TSLA
GM
F
STLA
CHPT
BLNK
PLUG
FCEL
BE
RUN
SEDG
ENPH
CRSP
MRNA
BMY
PFE
JNJ
GILD
AMGN
BIIB
REGN
AZN
LLY
ABBV
XOM
CVX
SHEL
TTE
COP
EOG
APA
OXY
XNET
UPST
SOFI
HOOD
COIN
MP
EXAS
TDOC
ON
NXPI
MRVL
ALGN
IDXX
VRTX
SNPS
CDNS
MCHP
ADI
AVGO
LRCX
ASML
KLAC
TER
GPN
LXU
ACI
XPER
NICE
BCC
FEED
DV
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
prnewswire.com
ABBV
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
prnewswire.com
ABBV
Antibody Therapeutics Market worth $597.1 billion by 2035 - Exclusive Report by MarketsandMarkets™
prnewswire.com
ABBV
MRK
BMY
JNJ
AMGN
REGN